
Medicross Medicaments Limited
Founded in 2011 and headquartered in Delhi, India.
Founded in 2011 and headquartered in Delhi, India.
West Delhi, Delhi, India
+91-XXXXXXXXXX
U24232DL2011PLC213715
213715
Public Limited Indian Non-Government Company
10 Feb 2011
-
-
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sunil Sharma ![]() | Director | 10-Feb-2011 | Current |
Bijender Jain ![]() | Director | 10-Feb-2011 | Current |
Neeraj Deewan ![]() | Director | 10-Feb-2011 | Current |
Enhance accessibility to Medicross Medicaments's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Medicross Medicaments's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Bijender Jain and Sunil Sharma are mutual person
Bijender Jain is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Medicross Medicaments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medicross Medicaments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medicross Medicaments's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Bijender Kumar Jain was appointed as a Director was appointed as a Director on 10 Feb 2011 & has been associated with this company since 14 years 1 month .
Sunil Kumar Sharma was appointed as a Director was appointed as a Director on 10 Feb 2011 & has been associated with this company since 14 years 1 month .
Neeraj Deewan was appointed as a Director was appointed as a Director on 10 Feb 2011 & has been associated with this company since 14 years 1 month .
Medicross Medicaments Limited was registered on 10 Feb 2011 with Roc Delhi & aged 14 years 1 month as per MCA records.
Medicross Medicaments Limited was incorporated on 10 Feb 2011.
The authorized share capital of Medicross Medicaments Limited is ₹ 0.50 M and paid-up capital is ₹ 0.50 M.
Currently 3 directors are associated with Medicross Medicaments Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Medicross Medicaments Limited is 107-112 Aggarwal Plaza F-Block, Dda Shopping Complex Vikas Puri, New Delhi, India, 110018.
The corporate identification number (CIN) of Medicross Medicaments Limited is U24232DL2011PLC213715 and the company number is 213715 as per Ministry of Corporate Affairs (MCA).
Search company & director profiles for free and gain access to critical business data.